Share on Pinterest
Share with your friends










Submit

Cost of healthcare in the U.S.

Bernie Sanders attacks pharma

Row of Medication of Shelf

KEY TAKEAWAY: Drug prices, and big pharma, are going to be squarely in the crosshairs of big pharma in the next general election. He echoes the sentiments of a lot of the American Public and you can bet that insurers, as well as politicians, are going to do something about it to win votes. Continue reading »

Oncology pipeline huge, but costly

oncology-drugs-250x250KEY TAKEAWAY: The oncology drug pipeline is far larger than any other therapy area across the pharmaceutical industry, with 6,484 products in active development across all indications, but 90% of these drugs will not make it into Phase III clinical trials. Continue reading »

Novartis goes “beyond the pill”

UnknownKEY TAKEAWAY: At $12.50 per patient a day, Entresto carries a substantially higher price tag than the older drugs, which cost less than a dollar a dose.  However, Novartis is deploying digital tools to prove to insurers that their drug has better outcomes which, in turn, leads to lower long-term health care costs. Continue reading »

Patients, shareholders take aim at Vertex

Bad NewsKEY TAKEAWAY: Vertex, who is based in downtown Boston, got the kind of headlines that pharma has been trying to avoid.  Three stories, talk about the high price of their new CF drug and the urges shareholders to reject compensation packages for senior executives.

Continue reading »

The real faces of high drug costs

UnknownKEY TAKEAWAY: Biopharma can’t just read about high drug prices in media stories, employees need to get out and listen to patients talk about how it’s affecting their treatment choices and limiting the quality of life THEY want. Continue reading »

On high drug prices…

imagesKEY TAKEAWAY: A report released this week during the largest gathering of biotechnology executives in the world found that pharmaceutical companies are more worried than they were a year ago about their ability to prevail in drug price negotiations. If the M&A frenzy among insurers continues drug companies could find out just how bad a strategy of high drug prices really is. Continue reading »

Prescription drug costs soaring

screenshot_27910 selected new medications are likely to result in medication costs to the government of $49.3 billion over a 10-year period, including: $31.3 billion in Medicare spend; $15.8 billion in state and federal Medicaid spend; and $2.1 billion as a result of subsidies provided through exchange plans. Continue reading »